Home/Investors/GL Ventures GL Ventures
Biotech Investor · 13 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| CureGene | preclinical | — | Oncology, Genetic Disorders |
| Escugen | preclinical | — | Genetic Disorders, Oncology |
| Codone Biotechnology | preclinical | — | Genetics & Genomics |
| Antengene | commercial | — | Oncology, Immunology |
| Ractigen Therapeutics | preclinical | — | Genetics & Genomics, Oncology |
| Triastek | phase-2 | — | Gastrointestinal Diseases, Central Nervous System Diseases |
| Delova Biotech | phase-1 | — | Oncology |
| Taron Solutions | platform | — | CNS, Infectious Disease |
| Westlake Genetech | commercial | — | Genetics, Oncology |
| Kanglin Biotechnology | phase-1 | — | Oncology, Immunology |
| TCRCure | phase-1 | — | Oncology, Infectious Disease |
| Transcend Vivoscope | commercial | — | Oncology, Surgery |
| Coyote Bioscience | commercial | — | Infectious Disease, Diagnostics |